Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis

Details for Australian Patent Application No. 2007338771 (hide)

Owner Merrimack Pharmaceuticals, Inc.

Inventors Stewart, Edward J.; Briskin, Michael

Agent Pizzeys

Pub. Number AU-A-2007338771

PCT Pub. Number WO2008/079270

Priority 60/876,027 19.12.06 US

Filing date 19 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/555 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079270 Priority application(s): WO2008/079270

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338783-Vent valve assemblies for baby bottles

2007338754-5-cyan0-4- (pyrrolo [2, 3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors